Nutex Health is trading 12.77% up now at $182.77 after investors continued rewarding its August 6, 2026 second-quarter earnings beat.
- Adjusted earnings reached $9.38 per share versus the $4.88 estimate.
- Sharply lower arbitration-related costs, a HaloMD contract amendment, stronger margins, and improved cash generation outweighed slightly weaker revenue.
- No separate August 10, 2026 company announcement was identified; broader markets were mixed, so the earnings reaction appears to be the primary catalyst.